Massachusetts 2025-2026 Regular Session

Massachusetts House Bill H1858

Introduced
2/27/25  

Caption

Relative to removing criminal penalties for limited psilocybin possession

Impact

This bill amends Chapter 94C of the General Laws, effectively decriminalizing limited possession of psilocybin. It applies solely to individuals caught with one gram or less and creates exemptions for several groups, including military veterans, first responders, and individuals with documented mental or physical health conditions. By implementing a Psilocybin Fines Trust Fund, the bill ensures that the collected penalties will support community harm reduction services, public health education, and outreach programs, potentially improving local public health initiatives.

Summary

House Bill 1858, known as the Psilocybin Possession Decriminalization and Community Support Act of 2025, seeks to remove criminal penalties for the possession of one gram or less of psilocybin and psilocin in Massachusetts. The bill introduces a civil penalty system that replaces the criminal penalties associated with such possession, imposing instead a $100 civil fine and the forfeiture of the controlled substance. The intent of this legislation is to reduce the legal repercussions surrounding psilocybin possession, which supporters argue will promote harm reduction and public safety.

Contention

Despite its intentions, HB 1858 has faced opposition from certain stakeholders who argue that decriminalizing psilocybin possession could have negative implications for public safety and mental health. Critics express concerns about the potential for increased accessibility and usage of psilocybin, particularly among vulnerable populations. Additionally, there is debate surrounding the adequacy of harm reduction approaches and whether they will effectively address the complexities of substance use and mental health issues.

Notable_points

The bill includes provisions that exempt individuals based on therapeutic needs and participation in clinical research. It emphasizes the need for privacy rights, especially concerning mental health documentation required for exemptions. There is also a structured approach for grant distribution to qualifying organizations, which aims to empower smaller community-based entities in their efforts to provide crucial services. Overall, while HB 1858 aims to promote a more compassionate and nuanced approach to psilocybin possession, the ongoing discourse underscores the complexity of drug policy reform.

Companion Bills

MA H5281

Replaced by Study Order

Previously Filed As

MA S1113

Relative to removing criminal penalties for limited psilocybin possession

MA H1726

Relative to criminal disposition of limited psilocybin possession offenses

MA HB528

Amending the penalties for the possession and use of psilocybin for persons 18 years of age or older.

MA HB06380

An Act Decriminalizing The Possession Of Psilocybin.

MA H2532

Relative to therapeutic psilocybin treatment centers

MA H1624

Establishing a task force to study equitable access to psilocybin and other entheogenic plants

MA H4986

Relative to therapeutic psilocybin treatment centers

MA SB219

Medical Psilocybin Act

MA HB07065

An Act Concerning The Decriminalization Of Possession Of Small Amounts Of Psilocybin.

MA LD1034

An Act to Decriminalize Personal Possession of Therapeutic Amounts of Psilocybin for Adults

Similar Bills

NH HB1796

Allowing the use of psilocybin in approved clinical settings to treat qualified medical conditions.

IA HF978

A bill for an act relating to the production and administration of psilocybin, and providing penalties. (Formerly HF 620.)

IA HF620

A bill for an act relating to the production of psilocybin and the administration of psilocybin to persons with post-traumatic stress disorder, and providing penalties.(See HF 978.)

IA HF2085

A bill for an act relating to the production and administration of psilocybin and providing penalties.

NJ S3148

"Psilocybin Behavioral Health Access and Services Act"; authorizes production and use of psilocybin to promote health and wellness.

NH HB1809

Establishing a medical psilocybin advisory board to assess the advantages and disadvantages of the use of psilocybin for therapeutic purposes.

NM SB219

Medical Psilocybin Act

MA H4050

To amend the General Laws, in relation to promoting the health and well-being of the residents of the Commonwealth of Massachusetts by establishing a comprehensive framework supporting public health and safety through regulated adult use, support services, and cultivation of psilocybin-containing fungi; and providing for taxation and appropriation thereof